U.S. President Joe Biden has been diagnosed with an aggressive form of prostate cancer, according to a statement released by the White House medical team. The news has prompted concern both in the United States and globally, given the seriousness of the condition and Biden’s role as a sitting president. The statement emphasized, however, that while the cancer is classified as aggressive, it remains hormone-sensitive—a factor that offers a range of effective treatment options.
Doctors are reportedly optimistic about managing the disease, noting that hormone-sensitive prostate cancers often respond well to targeted therapies. The president’s medical team is currently evaluating a comprehensive treatment plan, in consultation with his family. Biden, who has maintained a rigorous schedule and active public presence despite his age, is expected to continue performing his duties while undergoing treatment, though modifications to his schedule may be necessary.
The announcement has sparked an outpouring of support from world leaders, political colleagues, and citizens alike, with many expressing confidence in Biden’s resilience. Prostate cancer is among the most common cancers in older men, and advancements in treatment have significantly improved prognosis in recent years. The administration has committed to providing regular updates on the president’s health status as treatment progresses.